BRCA1/2 mutation screening in high-risk breast/ovarian cancer families and sporadic cancer patient surveilling for hidden high-risk families.
about
High expression of miR-214 is associated with a worse disease-specific survival of the triple-negative breast cancer patients.Time to rethink the capture and use of family history in primary care.Aggregate penetrance of genomic variants for actionable disorders in European and African Americans.High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population.
P2860
BRCA1/2 mutation screening in high-risk breast/ovarian cancer families and sporadic cancer patient surveilling for hidden high-risk families.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
BRCA1/2 mutation screening in ...... for hidden high-risk families.
@ast
BRCA1/2 mutation screening in ...... for hidden high-risk families.
@en
BRCA1/2 mutation screening in ...... for hidden high-risk families.
@nl
type
label
BRCA1/2 mutation screening in ...... for hidden high-risk families.
@ast
BRCA1/2 mutation screening in ...... for hidden high-risk families.
@en
BRCA1/2 mutation screening in ...... for hidden high-risk families.
@nl
prefLabel
BRCA1/2 mutation screening in ...... for hidden high-risk families.
@ast
BRCA1/2 mutation screening in ...... for hidden high-risk families.
@en
BRCA1/2 mutation screening in ...... for hidden high-risk families.
@nl
P2093
P2860
P356
P1433
P1476
BRCA1/2 mutation screening in ...... for hidden high-risk families.
@en
P2093
Andris Gardovskis
Arvids Irmejs
Dace Berzina
Dagnija Kalniete
Edvins Miklasevics
Janis Gardovskis
Jekaterina Zestkova
Karina Aksenoka
Miki Nakazawa-Miklasevica
P2860
P2888
P356
10.1186/1471-2350-14-61
P577
2013-06-14T00:00:00Z
P5875
P6179
1006179614